Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 06, 2023

SELL
$145.48 - $175.02 $31,278 - $37,629
-215 Reduced 1.62%
13,065 $2.17 Million
Q4 2022

Jan 06, 2023

BUY
$131.14 - $157.47 $39,735 - $47,713
303 Added 2.33%
13,280 $0
Q2 2022

Jul 01, 2022

SELL
$155.97 - $200.09 $69,874 - $89,640
-448 Reduced 3.34%
12,977 $2.23 Million
Q1 2022

Apr 12, 2022

BUY
$181.39 - $234.03 $67,839 - $87,527
374 Added 2.87%
13,425 $2.53 Million
Q4 2021

Jan 31, 2022

SELL
$193.69 - $247.03 $1,743 - $2,223
-9 Reduced 0.07%
13,051 $3.19 Million
Q3 2021

Oct 28, 2021

BUY
$189.29 - $209.69 $16,089 - $17,823
85 Added 0.66%
13,060 $2.54 Million
Q2 2021

Aug 12, 2021

SELL
$155.9 - $187.99 $590,861 - $712,482
-3,790 Reduced 22.61%
12,975 $2.42 Million
Q1 2021

May 12, 2021

BUY
$144.0 - $169.39 $373,104 - $438,889
2,591 Added 18.28%
16,765 $2.64 Million
Q4 2020

Feb 05, 2021

BUY
$157.07 - $174.35 $95,655 - $106,179
609 Added 4.49%
14,174 $2.35 Million
Q3 2020

Oct 29, 2020

BUY
$137.1 - $165.37 $580,755 - $700,507
4,236 Added 45.41%
13,565 $2.24 Million
Q2 2020

Jul 31, 2020

BUY
$111.92 - $142.53 $335,200 - $426,877
2,995 Added 47.28%
9,329 $1.28 Million
Q1 2020

Apr 21, 2020

SELL
$92.66 - $144.94 $1.06 Million - $1.66 Million
-11,486 Reduced 64.46%
6,334 $745,000
Q4 2019

Feb 21, 2020

BUY
$116.25 - $133.25 $28,365 - $32,513
244 Added 1.39%
17,820 $2.36 Million
Q3 2019

Nov 06, 2019

BUY
$112.57 - $128.43 $229,079 - $261,355
2,035 Added 13.09%
17,576 $2.19 Million
Q2 2019

Aug 06, 2019

BUY
$97.98 - $114.28 $362,428 - $422,721
3,699 Added 31.24%
15,541 $1.76 Million
Q1 2019

Apr 24, 2019

BUY
$81.56 - $100.67 $56,357 - $69,562
691 Added 6.2%
11,842 $1.19 Million
Q4 2018

Feb 12, 2019

BUY
$79.28 - $95.27 $884,051 - $1.06 Million
11,151 New
11,151 $954,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Insight Wealth Strategies, LLC Portfolio

Follow Insight Wealth Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight Wealth Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Insight Wealth Strategies, LLC with notifications on news.